ADVI Health’s Lindsay Bealor Greenleaf Mentioned in Pharmaceutical Executive

ADVI Health’s senior vice president and head, market access policy strategy (MAPS), Lindsay Bealor Greenleaf, was featured in Pharmaceutical Executive’s recent article, “Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report,” examining the administration’s expected expansion of voluntary Most Favored Nation (MFN) drug pricing agreements.

Lindsay discussed how MFN pricing would be achieved in Medicaid through a rebate construct and what these voluntary agreements could mean for manufacturers, patient out-of-pocket costs, and access.

Read the full article

---

Lindsay Bealor Greenleaf, JD, MBA
Senior Vice President, Market Access and Policy Strategy